Apremilast

Apremilast (Otezla) is an oral PDE4 inhibitor for psoriatic arthritis, psoriasis, and Behçet's disease. Learn about its uses, dosage, and side effects.

Apremilast apremilast for psoriasis apremilast psoriatic arthritis apremilast mechanism of action apremilast side effects apremilast dosage Otezla uses oral apremilast
🏷 ATC Code: L04AA32 📂 Immunosuppressants, selective immunosuppressants 🕐 Updated: Mar 13, 2026 ✓ Medical Reference

Looking to order Apremilast?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Apremilast?

Apremilast is an oral medication used to treat specific inflammatory conditions. It belongs to a class of drugs called phosphodiesterase 4 (PDE4) inhibitors, which work by modulating the immune system. Marketed under the brand name Otezla, it offers a systemic treatment option, especially for patients who haven't responded to other therapies. Unlike biologics, Apremilast is taken orally, making it a convenient choice. It helps reduce the overactive immune response driving conditions like psoriasis and psoriatic arthritis.

How Does it Work?

Apremilast acts by inhibiting phosphodiesterase 4 (PDE4), an enzyme found in inflammatory cells. PDE4 is crucial in producing pro-inflammatory mediators and breaking down cyclic adenosine monophosphate (cAMP). By inhibiting PDE4, Apremilast increases intracellular cAMP levels, leading to reduced production of pro-inflammatory cytokines (e.g., TNF-alpha, IL-17, IL-23) and increased anti-inflammatory mediators (e.g., IL-10). This mechanism helps modulate the immune response, reducing systemic inflammation and alleviating symptoms of chronic inflammatory diseases.

Medical Uses

Apremilast is approved for the treatment of several chronic inflammatory conditions in adults:

  • Psoriatic Arthritis (PsA): For active psoriatic arthritis, it helps reduce joint pain, swelling, and stiffness, improving physical function.
  • Moderate to Severe Plaque Psoriasis: For patients eligible for phototherapy or systemic therapy, Apremilast aids in clearing skin lesions and reducing itching and scaling.
  • Oral Ulcers Associated with Behçet's Disease: It treats debilitating oral ulcers linked to this rare, chronic inflammatory disorder.

Dosage

Apremilast dosage typically involves a gradual titration to minimize gastrointestinal side effects.

  • Initial Dosing (Titration): Patients usually start with 10 mg once daily, gradually increasing over five days to reach the maintenance dose.
    • Day 1: 10 mg AM
    • Day 2: 10 mg AM, 10 mg PM
    • Day 3: 10 mg AM, 20 mg PM
    • Day 4: 20 mg AM, 20 mg PM
    • Day 5: 20 mg AM, 30 mg PM
  • Maintenance Dose: The recommended dose is 30 mg twice daily, taken orally, with or without food.
  • Renal Impairment: For severe renal impairment, the dose is usually reduced to 30 mg once daily. Always follow your physician's instructions.

Side Effects

Apremilast can cause side effects, generally mild to moderate and often decreasing over time.

  • Common Side Effects:
    • Diarrhea, nausea, vomiting, abdominal pain
    • Headache, back pain, fatigue
    • Upper respiratory tract infections (e.g., common cold)
    • Weight loss (usually modest)
  • Less Common but Serious Side Effects:
    • Depression and Suicidal Thoughts: Monitor patients with a history of depression. Discontinue and consult a doctor if new or worsening depression occurs.
    • Significant Weight Loss: Report unexplained and substantial weight loss.
    • Hypersensitivity Reactions: Rare severe allergic reactions are possible.

Discuss any concerns with your healthcare provider.

Drug Interactions

Apremilast is metabolized by the cytochrome P450 enzyme system, mainly CYP3A4. Strong CYP450 enzyme inducers can significantly reduce Apremilast exposure, potentially decreasing its efficacy.

  • Strong CYP450 Inducers:
    • Rifampin
    • Phenobarbital
    • Carbamazepine
    • Phenytoin
    • St. John's Wort

Concomitant use with these is generally not recommended. Inform your doctor about all medications, supplements, and herbal products you are taking.

FAQ

  • Q: Is Apremilast an immunosuppressant?
    • A: Yes, it's an immunomodulator, a type of immunosuppressant. It targets specific inflammatory pathways rather than broadly suppressing the immune system.
  • Q: How long does it take for Apremilast to work?
    • A: Effects can be seen within weeks, but full benefits, especially for skin lesions, may take several months.
  • Q: Can Apremilast cause weight loss?
    • A: Yes, mild to moderate weight loss is a common side effect. Report significant, unexplained weight loss to your doctor.
  • Q: What is the brand name for Apremilast?
    • A: The most common brand name is Otezla.

Products containing Apremilast are available through trusted online pharmacies. You can browse Apremilast-based medications at ShipperVIP or Medicenter.

Summary

Apremilast is an oral immunomodulator for chronic inflammatory conditions like psoriatic arthritis, moderate to severe plaque psoriasis, and Behçet's disease-associated oral ulcers. As a PDE4 inhibitor, it reduces systemic inflammation. While generally well-tolerated, common side effects include gastrointestinal issues and headaches. Patients should follow prescribed dosages and be aware of drug interactions, especially with strong CYP450 inducers. Regular medical consultation ensures safe and effective treatment.